Vinorelbine—gemcitabine in advanced non-small-cell lung cancer (NSCLC): An AASLC phase II trial
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (8) , 993-998
- https://doi.org/10.1023/a:1008370704612
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinomaCancer, 2000
- Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancerAnnals of Oncology, 1999
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of Clinical Oncology, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)Annals of Oncology, 1995
- Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancerBritish Journal of Cancer, 1995
- Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-CCancer Chemotherapy and Pharmacology, 1995
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958